API SUPPLIERS

API Suppliers

2

US DMFs Filed

1

CEP/COS Certifications

0

JDMFs Filed

0

Other Certificates

1

Other Suppliers

0

API REF. PRICE (USD / KG)

0

API Market Place

3

INTERMEDIATES

0

DOSSIERS // FDF

USA (Orange Book)

3

Europe

5

Canada

0

Australia

58

South Africa

13

Uploaded Dossiers

31

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

FDF Market Place

2

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Full Screen View

Lincoln Pharmaceuticals

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Lincoln Pharma Plans to Launch Cephalosporin Products

Details:

The cephalosporins including cefalexin oral suspension BP, clavulanate tablets, cefixime capsules, cefuroxime axetil tablets to treat bacterial infections such as pneumonia and skin infections and also looks to export in African, Latin America and Southeast Asia markets.

Lead Product(s): Cephalexin Hydrochloride

Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 21, 2021

ASK
US